![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 2 of 2. This is the beginning of the thread.
Posted by SaraG on December 11, 2003, at 13:12:46
Is there news concerning when the FDA will finally allow Lilly's newest antidepressant, Cymbalta (Duloxetine), to be sold in the U.S.? Like Effexor, it "speaks to" both Norepinephrine and Serotinin. A new study in yesterday's Medscape online (www.medscape.com) compares it to Effexor, and shows it to be more "active" for most patients. I've been on Effexor-XR for about 5 years, but this round of "Severe Depression, Recurrent" is not lifting after ~ 2 1/2 years. Thoughts (suggestions, personal experiences) as well as information about Cymbalta will be appreciated.
Posted by SLS on December 11, 2003, at 13:40:06
In reply to Duloxetine (Cymbalta), posted by SaraG on December 11, 2003, at 13:12:46
Hi.
For now, Lilly is suggesting that Cymbalta might be ready for shipment in summer 2004. Even if the FDA approves it tomorrow, they still have to manufacture enough to be able to distrubute.
Many Effexor responders are also responders to MAOIs like Nardil and Parnate. Otherwise, it might be fruitful to add Remeron 30-45mg or Wellbutrin 150-300mg.
- Scott
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.